Sonu Subudhi, M.B.,B.S., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chiroptera | 6 | 2020 | 62 | 2.690 |
Why?
|
Gammaherpesvirinae | 2 | 2018 | 27 | 1.240 |
Why?
|
Models, Immunological | 1 | 2022 | 518 | 0.660 |
Why?
|
Hibernation | 1 | 2018 | 48 | 0.620 |
Why?
|
Disease Reservoirs | 1 | 2019 | 123 | 0.620 |
Why?
|
Coronavirus | 2 | 2018 | 156 | 0.610 |
Why?
|
Rift Valley fever virus | 1 | 2018 | 5 | 0.610 |
Why?
|
Rift Valley Fever | 1 | 2018 | 5 | 0.610 |
Why?
|
Cattle Diseases | 1 | 2018 | 50 | 0.590 |
Why?
|
Herpesviridae Infections | 1 | 2018 | 269 | 0.560 |
Why?
|
Virus Activation | 1 | 2018 | 324 | 0.540 |
Why?
|
Virus Latency | 1 | 2019 | 360 | 0.520 |
Why?
|
Viruses | 1 | 2019 | 373 | 0.490 |
Why?
|
Arousal | 1 | 2018 | 1183 | 0.410 |
Why?
|
Antibodies, Viral | 3 | 2018 | 3216 | 0.350 |
Why?
|
Gene Expression | 1 | 2021 | 7602 | 0.310 |
Why?
|
Losartan | 3 | 2024 | 262 | 0.300 |
Why?
|
Disease Outbreaks | 1 | 2018 | 1761 | 0.300 |
Why?
|
Virus Replication | 4 | 2020 | 2458 | 0.290 |
Why?
|
Immunologic Memory | 2 | 2021 | 1378 | 0.230 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3116 | 0.220 |
Why?
|
Hepacivirus | 2 | 2021 | 1344 | 0.220 |
Why?
|
Tumor Microenvironment | 3 | 2024 | 3951 | 0.200 |
Why?
|
Phylogeny | 3 | 2020 | 2843 | 0.200 |
Why?
|
Latent Tuberculosis | 1 | 2024 | 224 | 0.180 |
Why?
|
Reassortant Viruses | 1 | 2020 | 36 | 0.180 |
Why?
|
Algorithms | 1 | 2020 | 14199 | 0.170 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2024 | 1942 | 0.160 |
Why?
|
Obesity | 1 | 2021 | 13087 | 0.160 |
Why?
|
Hepatitis B, Chronic | 1 | 2023 | 413 | 0.160 |
Why?
|
Virus Shedding | 1 | 2019 | 110 | 0.150 |
Why?
|
Mali | 1 | 2018 | 50 | 0.150 |
Why?
|
Ascomycota | 1 | 2018 | 81 | 0.150 |
Why?
|
Haplorhini | 1 | 2018 | 524 | 0.140 |
Why?
|
Aedes | 1 | 2018 | 101 | 0.140 |
Why?
|
Open Reading Frames | 1 | 2020 | 818 | 0.140 |
Why?
|
Cats | 1 | 2018 | 978 | 0.130 |
Why?
|
Seroepidemiologic Studies | 1 | 2018 | 405 | 0.130 |
Why?
|
Neutralization Tests | 1 | 2018 | 739 | 0.130 |
Why?
|
Mycoses | 1 | 2018 | 386 | 0.120 |
Why?
|
Point Mutation | 1 | 2020 | 1595 | 0.120 |
Why?
|
Metabolomics | 1 | 2024 | 1675 | 0.120 |
Why?
|
Animals | 12 | 2024 | 169408 | 0.120 |
Why?
|
Down-Regulation | 1 | 2021 | 2941 | 0.110 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2023 | 4651 | 0.110 |
Why?
|
Hepatitis C, Chronic | 1 | 2021 | 1033 | 0.110 |
Why?
|
Mycobacterium tuberculosis | 1 | 2024 | 1930 | 0.100 |
Why?
|
Canada | 1 | 2018 | 2129 | 0.100 |
Why?
|
Up-Regulation | 1 | 2021 | 4148 | 0.100 |
Why?
|
Cattle | 1 | 2018 | 3820 | 0.100 |
Why?
|
DNA, Viral | 1 | 2018 | 2205 | 0.100 |
Why?
|
Liver | 3 | 2023 | 7579 | 0.090 |
Why?
|
Tuberculosis | 1 | 2024 | 2029 | 0.090 |
Why?
|
Immune Tolerance | 1 | 2019 | 2323 | 0.080 |
Why?
|
Hepatitis C | 1 | 2020 | 1595 | 0.080 |
Why?
|
Viral Load | 1 | 2019 | 3398 | 0.080 |
Why?
|
Fibroblasts | 1 | 2020 | 4178 | 0.080 |
Why?
|
Polymerase Chain Reaction | 1 | 2018 | 6085 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2024 | 5342 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 1 | 2024 | 3200 | 0.080 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2022 | 2297 | 0.080 |
Why?
|
Swine | 1 | 2018 | 5998 | 0.070 |
Why?
|
Disease Progression | 2 | 2022 | 13677 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2024 | 4919 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 2024 | 4300 | 0.070 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4413 | 0.070 |
Why?
|
Genome, Viral | 2 | 2020 | 673 | 0.070 |
Why?
|
Humans | 17 | 2024 | 768887 | 0.070 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 8055 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2023 | 5443 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5892 | 0.060 |
Why?
|
Cell Line | 1 | 2018 | 15603 | 0.060 |
Why?
|
T-Lymphocytes | 1 | 2020 | 10276 | 0.050 |
Why?
|
Kidney | 3 | 2024 | 7057 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 11886 | 0.050 |
Why?
|
Granuloma | 1 | 2024 | 329 | 0.050 |
Why?
|
Receptors, Mineralocorticoid | 1 | 2022 | 167 | 0.050 |
Why?
|
Leucovorin | 1 | 2023 | 643 | 0.050 |
Why?
|
Principal Component Analysis | 1 | 2024 | 948 | 0.050 |
Why?
|
Host Specificity | 1 | 2020 | 56 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8745 | 0.040 |
Why?
|
Male | 5 | 2022 | 365249 | 0.040 |
Why?
|
Nucleocapsid Proteins | 1 | 2020 | 75 | 0.040 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2020 | 93 | 0.040 |
Why?
|
Female | 5 | 2024 | 397464 | 0.040 |
Why?
|
Receptor, IGF Type 1 | 1 | 2022 | 384 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 30044 | 0.040 |
Why?
|
Hepatitis B virus | 1 | 2023 | 533 | 0.040 |
Why?
|
United States | 2 | 2018 | 73180 | 0.040 |
Why?
|
Vero Cells | 1 | 2020 | 486 | 0.040 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2020 | 146 | 0.040 |
Why?
|
Lung | 1 | 2017 | 10097 | 0.040 |
Why?
|
Potassium | 1 | 2022 | 1319 | 0.040 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2020 | 435 | 0.040 |
Why?
|
Biopsy, Fine-Needle | 1 | 2023 | 1132 | 0.040 |
Why?
|
Fluorouracil | 1 | 2023 | 1655 | 0.040 |
Why?
|
Rabbits | 1 | 2024 | 4774 | 0.040 |
Why?
|
Risk Factors | 2 | 2022 | 74971 | 0.040 |
Why?
|
Aldosterone | 1 | 2022 | 881 | 0.040 |
Why?
|
Receptors, Virus | 1 | 2020 | 652 | 0.030 |
Why?
|
Interferon Type I | 1 | 2020 | 569 | 0.030 |
Why?
|
Recombination, Genetic | 1 | 2020 | 1526 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2023 | 1625 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 2024 | 1397 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2020 | 1246 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2023 | 2041 | 0.030 |
Why?
|
Fibrosis | 1 | 2022 | 2081 | 0.030 |
Why?
|
Epitopes | 1 | 2021 | 2529 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2022 | 2228 | 0.030 |
Why?
|
Viral Proteins | 1 | 2020 | 1802 | 0.030 |
Why?
|
Phenotype | 2 | 2021 | 16735 | 0.030 |
Why?
|
Protein Conformation | 1 | 2020 | 3956 | 0.030 |
Why?
|
Glucose | 1 | 2024 | 4352 | 0.020 |
Why?
|
Transfection | 1 | 2020 | 5763 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2023 | 2909 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2020 | 2820 | 0.020 |
Why?
|
Models, Molecular | 1 | 2020 | 5404 | 0.020 |
Why?
|
Adult | 2 | 2022 | 223818 | 0.020 |
Why?
|
RNA, Viral | 1 | 2018 | 2871 | 0.020 |
Why?
|
Middle Aged | 2 | 2021 | 223740 | 0.020 |
Why?
|
Intestines | 1 | 2018 | 1911 | 0.020 |
Why?
|
Base Sequence | 1 | 2020 | 12430 | 0.020 |
Why?
|
Aged | 1 | 2022 | 171790 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2021 | 3069 | 0.020 |
Why?
|
Immunotherapy | 1 | 2024 | 4755 | 0.020 |
Why?
|
Vaccination | 1 | 2020 | 3436 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2024 | 17174 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7609 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2018 | 3080 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2021 | 11684 | 0.010 |
Why?
|
Models, Biological | 1 | 2018 | 9499 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 11934 | 0.010 |
Why?
|
Mice | 1 | 2024 | 82074 | 0.010 |
Why?
|